Utah Urgently Halts AI Prescription Pilot: Where is the Boundary Between Medical Innovation and Patient Safety?
Utah's medical board has issued an order to immediately suspend the state's pioneering AI prescription renewal pilot project, turning this promising innovation into a stark example of AI regulatory challenges. The decision highlights the tension between advancing medical technology and ensuring patient safety, underscoring the need for robust regulatory frameworks in AI healthcare applications.